Newfound Research LLC Cooper Companies, Inc. Transaction History

Newfound Research LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$301.4 - $428.42 $56,060 - $79,686	-186 Reduced 50.82%	180 $56,000
Q1 2022 May 04, 2022	BUY	$379.46 - $424.54 $7,589 - $8,490	20 Added 5.78%	366 $153,000
Q4 2021 Jan 19, 2022	BUY	$373.53 - $434.12 $26,147 - $30,388	70 Added 25.36%	346 $145,000
Q3 2021 Oct 14, 2021	BUY	$396.76 - $455.92 $24,202 - $27,811	61 Added 28.37%	276 $114,000
Q2 2021 Jul 19, 2021	BUY	$372.36 - $412.07 $744 - $824	2 Added 0.94%	215 $85,000
Q1 2021 Apr 28, 2021	SELL	$357.26 - $392.57 $52,517 - $57,707	-147 Reduced 40.83%	213 $82,000
Q4 2020 Jan 22, 2021	BUY	$319.05 - $363.32 $114,858 - $130,795	360 New	360 $131,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

Stay updated on Newfound Research LLC with notifications on news.